The latest immunotherapy news and developments
New cellular immunotherapy approach shows promise for B-cell lymphoma
A new type of cell-based immunotherapy shows promise for B-cell lymphomas and — due to…
The latest immunotherapy news and developments
A new type of cell-based immunotherapy shows promise for B-cell lymphomas and — due to…
Opioids are often first-line treatments for cancer-related pain, but they can suppress the immune system…
A groundbreaking phase one clinical trial exploring a novel cell-based immunotherapy for breast cancer has…
Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies…
The Wistar Institute’s David B. Weiner, Ph.D. — Executive Vice President, director of the Vaccine & Immunotherapy…
A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential…
The addition of the immunotherapy drug pembrolizumab to the standard of care for patients with…
In recent years, scientists have created a range of new methods based on CRISPR-Cas technology…
Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to…
Researchers at the Icahn School of Medicine at Mount Sinai, USA, have discovered a way…